Breast Cancer Screening Linked to Higher Survival Rates, Even in Stage IV

New research offers a significant message of hope for women diagnosed with stage IV breast cancer. A study published in JNCI reveals that women whose cancer is detected through routine screening have a substantially higher chance of long-term survival – a 60% ten-year survival rate – compared to those whose cancer is discovered after symptoms appear, who have a survival rate of under 20%.

The findings, stemming from a collaboration between King’s College London, Queen Mary University London, and the University of Southern Denmark, challenge the assumption that screening is ineffective once cancer has reached an advanced stage. Researchers aimed to determine whether the method of detection – screening versus symptomatic diagnosis – impacts survival rates across different stages of the disease.

“Our results show that how breast cancer is detected could impact the patient’s survival chances,” explained Dr. Amy Tickle, the lead author who completed the research during her PhD at King’s College London. “There is understandably a lot of fear around cancer being found late, but our findings provide reassurance that long-term survival is still possible when it is found during screening.”

The study analyzed data from over a decade, linking Danish breast screening records from 2010 to 2019 with national death records through 2022. Researchers compared mortality rates in women with breast cancer to those without, carefully accounting for screening history to minimize bias. This unique approach involved separately analyzing mortality in women who had never been screened, those previously screened but whose cancer wasn’t detected through screening, and those whose cancer was identified through screening.

While survival rates remained consistent across stages I, II, and III regardless of detection method, the researchers observed a striking difference in stage IV breast cancer. Women diagnosed through screening exhibited a prognosis more akin to those with stage III cancer, demonstrating a three-fold increase in the likelihood of living for another ten years compared to those diagnosed symptomatically.

The improved survival among screened patients appears linked to a greater opportunity for surgical intervention. The study suggests that cancers detected through screening, even at stage IV, were more likely to be limited in their spread, allowing for more complete surgical removal. This is a crucial distinction, as surgical resection remains a primary goal in cancer treatment.

Breast cancer screening programs, such as those offered by the National Health Service (NHS) in the UK, provide women aged 50 to 70 with mammograms every three years. These mammograms, which are X-ray images of the breast, aim to identify cancers before symptoms develop. Following an abnormal screening result, patients undergo further diagnostic assessment.

Peter Sasieni, Dr. Tickle’s former PhD supervisor at King’s College London, now at Queen Mary University of London, emphasized the broader implications of the research. “We looked at survival in women with screened detected breast cancer, in women who had never been screening and in women who had been screened previously but whose cancer was not detected through screening.”

The findings underscore the importance of continued participation in breast cancer screening programs. The authors also suggest that these results can be used to monitor the effectiveness of screening programs by tracking changes in the stage at which breast cancer is diagnosed. This allows for earlier assessment – within five to ten years – of whether modifications to screening protocols are yielding positive results, rather than relying solely on long-term mortality data.

Dr. Tickle added, “Our research highlights the importance of screening programs and we hope this encourages everyone who is invited to attend their appointment.” Further research is planned to delve deeper into the underlying reasons for this improved survival rate, potentially identifying specific factors that contribute to the positive outcomes observed in screened patients.

This study provides compelling evidence that even in the face of advanced breast cancer, early detection through screening can significantly improve a patient’s chances of long-term survival. It reinforces the value of proactive screening and offers a renewed sense of hope for those facing a stage IV diagnosis.